Multi-scale spatio-temporal analysis of colorectal cancer data
Official title: Multi-scale Spatio-Temporal Analysis of Research Data
Run by Universidad de Granada · NCT07189312 · Data updated 2026-11-12
This project will test a computer framework that uses tumor and omics data from colorectal cancer patients having planned surgery to make multi-scale maps of how the disease behaves across space and time.
Quick facts
| Study type | Observational |
|---|---|
| Ages | 18 Years to 90 Years |
| Sex | All |
| Enrollment | 15 (estimated) |
| Sponsor | Universidad de Granada Academic / other |
| Locations | 1 site (Granada, Granada) |
| Status | Recruiting |
| Started | February 2, 2025 |
| Main results expected | February 28, 2026 |
| Study ends | December 2, 2026 |
| Registry record updated | April 28, 2026 |
| Trial ID | NCT07189312 on ClinicalTrials.gov |
Is this trial a fit for you?
✓Likely a good fit
Adults with a diagnosis of colorectal cancer who are scheduled for planned surgery, who do not have microsatellite instability, and who have no other diseases that would affect the cancer pathology are the intended participants.
✕Probably not a fit
Patients requiring urgent surgery, those with microsatellite instability, or those with significant comorbidities that affect cancer pathology are unlikely to be eligible or to benefit from this project.
A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.
What this trial studies
This observational project will collect clinical and molecular data from colorectal cancer patients undergoing planned surgery and apply computational methods to build multi-scale spatio-temporal (ST) models with statistical inference. Investigators aim to integrate high-throughput omics, including single-cell and spatial measurements, to capture tumor heterogeneity and microenvironment patterns over space and time. The framework is intended as a common solution that can be adapted to different applications rather than a single-disease tool. The project is led by Universidad de Granada with clinical collaboration at Virgen de las Nieves Hospital in Granada, Spain.
Why it matters
Potential benefit: If successful, the framework could improve understanding of tumor progression and help guide more personalized treatment or surgical planning for colorectal cancer patients.
How similar studies have gone: Related single-cell and spatial omics studies have shown promise in mapping tumor biology, but a unified multi-scale spatio-temporal modeling framework of this type is relatively novel.
Who can join: the full rules
Show full inclusion / exclusion criteria
Inclusion Criteria: * Diagnosis for colorectal cancer * Patients with cancer planned surgery * Absence of instability microsatellites * Absence of any other associated disease that can affect the cancer pathology Exclusion Criteria: * Patients who need an urgent surgery
Where it's running
-
Virgen de las Nieves Hospital
Granada, Granada, Spain Recruiting
Study contacts
- Study coordinator: Jose Camacho, PhD
- Email: jcamacho@ugr.es
- Phone: +34 958248898
Similar studies
Other studies for the same condition or treatment. Recruiting studies are listed first.
-
Knife-assisted full-thickness resection for rectal lesions in a multicenter setting
A multicenter study tests knife-assisted full-thickness resection (kFTR) to remove rectal lesions in adults and see how well it works and how safe it is.
-
Personalized 3D Bioprinted Colorectal Cancer Microenvironment Model
This study tests patient-derived, 3D-bioprinted cancer models that include tumor, fibroblast, and immune cells to see if they can better predict how colorectal cancer will respond to treatment.
-
Integrated genomic and clinical database for cancer biomarker discovery
Researchers are building a combined genomic and clinical database at Samsung Medical Center to test biomarkers for cancer diagnosis, treatment choice, and predicting how well treatments work.
-
Prehabilitation with Resistance, Aerobic, or Both Before Colorectal Surgery
Four pre-surgery exercise options (resistance, aerobic, both, or none) will be tested to see which best reduces complications after colorectal cancer surgery.
-
Liver transplantation for colorectal cancer with liver metastases
This study follows adults with stage IV colorectal cancer whose disease is limited to the liver and who are getting a liver transplant as part of their cancer care to see how they fare over time.
-
LTZ-232: a first-in-human test in advanced colorectal and other solid tumors
A first-in-human study tests LTZ-232, a new therapy for adults with unresectable or metastatic colorectal cancer and other solid tumors that have not responded to standard treatments.
How to take part
- Review the eligibility criteria above with your treating physician.
- Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
- Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.